Journal Logo

January 2021 - Volume 77 - Issue 1
pp: 1-121

Review Article

Original Article

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure

Wohlford, George F.; Van Tassell, Benjamin W.; Billingsley, Hayley E.; More

Journal of Cardiovascular Pharmacology. 77(1):49-60, January 2021.

Angiotensin-Converting Enzyme Inhibitor–based Versus Angiotensin Receptor Blocker–based Optimal Medical Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study

Park, Sangwoo; Kim, Yong-Giun; Ann, Soe Hee; More

Journal of Cardiovascular Pharmacology. 77(1):61-68, January 2021.

Continuous Aerobic Exercise Prevents Detrimental Remodeling and Right Heart Myocyte Contraction and Calcium Cycling Dysfunction in Pulmonary Artery Hypertension

Silva, Franciany de Jesus; Drummond, Filipe Rios; Fidelis, Meilene Ribeiro; More

Journal of Cardiovascular Pharmacology. 77(1):69-78, January 2021.

Country-based Comparison of Atrial Fibrillation Patients' Preferences for Oral Anticoagulation: An Evaluation of Discrete Choice Experiments in Five Different Countries

Henry, Maren; Wosnitza, Melanie; Thate-Waschke, Inga-Marion; More

Journal of Cardiovascular Pharmacology. 77(1):100-106, January 2021.